Explores personalized medicine, genetic variability, and drug response, emphasizing tailoring treatments based on individual genetic and metabolic profiles.
Explores the genetic basis of Prader-Villy syndrome and its comparison with Angelman syndrome, emphasizing DNA methylation patterns and chromosomal abnormalities.